Elixxer Ltd.

Recent News

  • Elixxer Ltd. Corporate Update

    Montreal, Quebec--(Newsfile Corp. - November 17, 2022) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") announces that it is continuing its discussions with regard to a potential acquisition which have been ongoing since May of this year. Changes in the deal structure as well as delays in the completion of the audit have resulted in numerous setbacks in coming to final terms. In the interim, the Company has also been considering other potential opportunities in industries unrelated to cannabis....

    2022-11-17 4:31 PM EST
  • Elixxer Ltd. Announces Auditor Resignation

    Montreal, Quebec--(Newsfile Corp. - October 28, 2022) - Elixxer Ltd. (TSXV: ELXR) ("Elixxer" or the "Company") announces the resignation of its auditors, Baker Tilly WM LLP ("Baker"). Baker resigned on their own initiative, which resignation has been reviewed by the Company's board. Baker has advised that its resignation is a business decision of such firm and has confirmed that there are no reportable events, "disagreements" or "unresolved issues" (as those terms are defined in National Instrument 51-102 - Continuous...

    2022-10-28 2:45 PM EDT
  • Elixxer Ltd. Closes Amended Secured Loan with AIP Convertible Private Debt Fund L.P

    Montreal, Quebec--(Newsfile Corp. - May 25, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTC Pink: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has closed its previously announced (see press release of February 22, 2022) amended loan with AIP Convertible Private Debt Fund L.P., AIP Asset Management Inc. and related and affiliated companies ("AIP"). Further to the amendment, AIP has loaned the Company an additional $4 million (the "Additional Disbursement") which will: (i) have a maturity of...

    2022-05-25 9:20 AM EDT
  • Elixxer Ltd. Announces Trading Update

    Montreal, Quebec--(Newsfile Corp. - May 12, 2022) - Elixxer Ltd. (the "Corporation" or "Elixxer") (TSXV: ELXR) (OTCQB: ELXIF) announces that a cease trade order had been issued as a result of its failure to file its year end financial statements within the prescribed filing deadlines. The Corporation is pleased to report that its financial reporting is now up to date and has been advised that the cease trade order issued on May 11th, will be lifted imminently. About Elixxer Ltd....

    2022-05-12 10:39 AM EDT
  • Elixxer Received a Binding Offer to Sell Viridi Stake for $1 Million

    Montreal, Quebec--(Newsfile Corp. - March 29, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has received a binding offer for the sale of its 18.4% shareholdings in Viridi Unit SA to Global A Brands. The Global A Brands already owns the remaining 81.6% of Viridi. The binding offer values Elixxer's shares in Viridi at about CAN $1,000,000. The Company, under the previous management team, purchased the Viridi stocks on...

    2022-03-29 10:00 AM EDT
  • Elixxer Ltd. Announces Amended Secured Loan with AIP Convertible Private Debt Fund L.P.

    Montreal, Quebec--(Newsfile Corp. - February 22, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased to announce that it has entered into an agreement with AIP Convertible Private Debt Fund L.P. ("AIP") to amend its existing secured loan with AIP (the "Loan"). Further to the amendments, the principal amount of the Loan will increase to $8 million, with an additional $4 million being disbursed to the Company (the "Additional Disbursement"). The amended Loan will:...

    2022-02-22 8:29 AM EST
  • Elixxer's Investment in Italian Medical Cannabis (Evolution BNK) Shows Significant Revenue Growth

    Montreal, Quebec--(Newsfile Corp. - February 10, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is proud to announce that one of its investee companies, Evolution BNK ("Evolution") based in Pavia, Italy, is now fully operational. Over the course of 2021, Evolution completed its indoor growing facility and obtained all governmental approvals to initiate the harvesting of medical grade cannabis. Notwithstanding a very short production window for the period up to the end of December 2021, Evolution...

    2022-02-10 1:10 PM EST
  • Elixxer Bought Back and Cancelled 20.6 Million Shares as It Pursues Certain Opportunities for Its Future Expansion/Acquisition Plans

    Montreal, Quebec--(Newsfile Corp. - February 7, 2022) - Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) ("Elixxer" or the "Company) is pleased is to provide this update on its previously announced normal course issuer bid (the "Bid"). As of January 31, 2022, the Company has bought back for cancellation a total of 20,632,000 common shares on the open market at prices ranging from $0.01 to $0.02 per share, representing approximately 36.81% of the maximum number of common shares permitted to be purchased...

    2022-02-07 3:53 PM EST